Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Pollard

Showing results (31-40 of 679) with videos related to

Pageof 68
Sort By:
The Medical Journal of Australia|November 3, 2017
Trends in meningococcal disease: challenges for vaccine control when disease is rareAndrew J Pollard, Hannah Christensen
Early Human Development|September 21, 2010
Challenges in immunisation against bacterial infection in childrenJohannes Trück, Andrew J Pollard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2013
Characterizing vaccine responses using host genomic and transcriptomic analysisDaniel O'Connor, Andrew J Pollard
Journal of Travel Medicine|April 16, 2002
Epidemic meningococcal disease and travelAndrew J Pollard, David R Shlim
The Journal of Infection|April 29, 2015
Group B meningococcal vaccine science and policySimon B Drysdale, Andrew J Pollard
Expert Review of Vaccines|June 5, 2007
Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?Anoop S Pulickal, Andrew J Pollard
The Lancet. Infectious Diseases|December 29, 2004
Meningococcal polysaccharide-protein conjugate vaccinesMatthew D Snape, Andrew J Pollard
Expert Review of Vaccines|May 25, 2011
Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancyGeraldine Blanchard-Rohner, Andrew J Pollard
Paediatric Drugs|September 2, 2004
Meningococcal vaccinesJens U Rüggeberg, Andrew J Pollard
Nature Materials|March 27, 2020
Vaccine communication in a digital societyTonia M Thomas, Andrew J Pollard
Pageof 68

Showing results (31-40 of 679) with videos related to

Sort By:
Pageof 68
The Medical Journal of Australia|November 3, 2017
Trends in meningococcal disease: challenges for vaccine control when disease is rareAndrew J Pollard, Hannah Christensen
Early Human Development|September 21, 2010
Challenges in immunisation against bacterial infection in childrenJohannes Trück, Andrew J Pollard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2013
Characterizing vaccine responses using host genomic and transcriptomic analysisDaniel O'Connor, Andrew J Pollard
Journal of Travel Medicine|April 16, 2002
Epidemic meningococcal disease and travelAndrew J Pollard, David R Shlim
The Journal of Infection|April 29, 2015
Group B meningococcal vaccine science and policySimon B Drysdale, Andrew J Pollard
Expert Review of Vaccines|June 5, 2007
Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?Anoop S Pulickal, Andrew J Pollard
The Lancet. Infectious Diseases|December 29, 2004
Meningococcal polysaccharide-protein conjugate vaccinesMatthew D Snape, Andrew J Pollard
Expert Review of Vaccines|May 25, 2011
Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancyGeraldine Blanchard-Rohner, Andrew J Pollard
Paediatric Drugs|September 2, 2004
Meningococcal vaccinesJens U Rüggeberg, Andrew J Pollard
Nature Materials|March 27, 2020
Vaccine communication in a digital societyTonia M Thomas, Andrew J Pollard
Pageof 68